Swanbridge Capital is a Rotterdam based venture capital fund that actively invests in young, high potential companies in the life sciences. We focus on companies that are in very early stage in their development of therapeutics, diagnostics and medical devices. Our team is committed to actively support our portfolio companies in their quest for success.

Latest News

Swanbridge Capital announced it has invested in IPaDiC, a private company developing an implantable insulin pump for diabetes type 1 patients with an insulin resistance.

Read more

Meet us at

Healthy Funding

28 JuneĀ – Rotterdam

Read more

Swanbridge Capital
Brainpark II - Building XI
Lichtenauerlaan 40
3062 ME Rotterdam


© 2016 Swanbridge Capital